Literature DB >> 11551733

A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder.

J Copeland1, W Swift, R Roffman, R Stephens.   

Abstract

The increasing demand for treatment for cannabis dependence in Australia and internationally has led to the identification of significant gaps in knowledge of effective interventions. A randomized controlled trial of brief cognitive-behavioral interventions (CBT) for cannabis dependence was undertaken to address this issue. A total of 229 participants were assessed and randomly assigned to either a six-session CBT program (6CBT), a single-session CBT intervention (1CBT), or a delayed-treatment control (DTC) group. Participants were assisted in acquiring skills to promote cannabis cessation and maintenance of abstinence. Participants were followed-up a median of 237 days after last attendance. Participants in the treatment groups reported better treatment outcomes than the DTC group. They were more likely to report abstinence, were significantly less concerned about their control over cannabis use, and reported significantly fewer cannabis-related problems than those in the DTC group. Those in the 6CBT group also reported more significantly reduced levels of cannabis consumption than the DTC group. While the therapist variable had no effect on any outcome, a secondary analysis of the 6CBT and 1CBT groups showed that treatment compliance was significantly associated with decreased dependence and cannabis-related problems. This study supports the attractiveness and effectiveness of individual CBT interventions for cannabis use disorders and the need for multisite replication trials.

Entities:  

Mesh:

Year:  2001        PMID: 11551733     DOI: 10.1016/s0740-5472(01)00179-9

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  76 in total

Review 1.  State of the art treatments for cannabis dependence.

Authors:  Itai Danovitch; David A Gorelick
Journal:  Psychiatr Clin North Am       Date:  2012-04-10

Review 2.  The marijuana withdrawal syndrome: diagnosis and treatment.

Authors:  Margaret Haney
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 3.  Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Authors:  Robert M Roth; Mary F Brunette; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

4.  Randomized controlled trial of personalized motivational interventions in substance using patients with facial injuries.

Authors:  Vivek Shetty; Debra A Murphy; Corwin Zigler; Dennis-Duke R Yamashita; Thomas R Belin
Journal:  J Oral Maxillofac Surg       Date:  2011-04-15       Impact factor: 1.895

Review 5.  Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI.

Authors:  Hudaisa Fatima; Allyn C Howlett; Christopher T Whitlow
Journal:  Br J Radiol       Date:  2019-08-09       Impact factor: 3.039

6.  Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.

Authors:  Dustin C Lee; Nicolas J Schlienz; Erica N Peters; Robert H Dworkin; Dennis C Turk; Eric C Strain; Ryan Vandrey
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

Review 7.  Substance Use in the Perinatal Period.

Authors:  Ariadna Forray; Dawn Foster
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

8.  METelemedicine: a pilot study with rural alcohol users on community supervision.

Authors:  Michele Staton-Tindall; Jennifer R Havens; J Matthew Webster; Carl Leukefeld
Journal:  J Rural Health       Date:  2014-05-06       Impact factor: 4.333

Review 9.  Role of endocannabinoid system in mental diseases.

Authors:  Jorge Manzanares; Leyre Urigüen; Gabriel Rubio; Tomás Palomo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

10.  Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.

Authors:  Molly Magill; Lara A Ray
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.